| Year |
Citation |
Score |
| 2023 |
Spencer RC, Martin AJ, Devilbiss DM, Berridge CW. Cognition-enhancing and cognition-impairing doses of psychostimulants exert opposing actions on frontostriatal neural coding of delay in working memory. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 37741905 DOI: 10.1038/s41386-023-01738-6 |
0.732 |
|
| 2023 |
Berridge CW, Devilbiss DM, Martin AJ, Spencer RC, Jenison RL. Stress degrades working memory-related frontostriatal circuit function. Cerebral Cortex (New York, N.Y. : 1991). PMID 36935095 DOI: 10.1093/cercor/bhad084 |
0.726 |
|
| 2022 |
Berridge CW, Martin AJ, Hupalo S, Nicol SE. Estrus cycle-dependent working memory effects of prefrontal cortex corticotropin-releasing factor neurotransmission. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 35618840 DOI: 10.1038/s41386-022-01349-7 |
0.312 |
|
| 2021 |
Hupalo S, Spencer RC, Berridge CW. Prefrontal Corticotropin-Releasing Factor Neurons Impair Sustained Attention via Distal Transmitter Release. The European Journal of Neuroscience. PMID 33949025 DOI: 10.1111/ejn.15260 |
0.39 |
|
| 2020 |
Poe GR, Foote S, Eschenko O, Johansen JP, Bouret S, Aston-Jones G, Harley CW, Manahan-Vaughan D, Weinshenker D, Valentino R, Berridge C, Chandler DJ, Waterhouse B, Sara SJ. Locus coeruleus: a new look at the blue spot. Nature Reviews. Neuroscience. PMID 32943779 DOI: 10.1038/S41583-020-0360-9 |
0.624 |
|
| 2019 |
Hupalo S, Bryce CA, Bangasser DA, Berridge CW, Valentino RJ, Floresco SB. Corticotropin-Releasing Factor (CRF) circuit modulation of cognition and motivation. Neuroscience and Biobehavioral Reviews. 103: 50-59. PMID 31212019 DOI: 10.1016/J.Neubiorev.2019.06.010 |
0.423 |
|
| 2019 |
Spencer RC, Berridge CW. Receptor and circuit mechanisms underlying differential procognitive actions of psychostimulants. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 30683912 DOI: 10.1038/S41386-019-0314-Y |
0.435 |
|
| 2019 |
Hupalo S, Martin AJ, Green RK, Devilbiss DM, Berridge CW. Prefrontal Corticotropin-Releasing Factor (CRF) Neurons Act Locally to Modulate Frontostriatal Cognition and Circuit Function. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 30651328 DOI: 10.1523/Jneurosci.2701-18.2019 |
0.752 |
|
| 2018 |
Foote SL, Berridge CW. New developments and future directions in understanding locus coeruleus - Norepinephrine (LC-NE) function. Brain Research. PMID 30267649 DOI: 10.1016/J.Brainres.2018.09.033 |
0.322 |
|
| 2016 |
Hupalo S, Berridge CW. Working Memory Impairing Actions of Corticotropin-Releasing Factor (CRF) Neurotransmission in the Prefrontal Cortex. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 27272767 DOI: 10.1038/Npp.2016.85 |
0.462 |
|
| 2016 |
Devilbiss DM, Spencer RC, Berridge CW. Stress Degrades Prefrontal Cortex Neuronal Coding of Goal-Directed Behavior. Cerebral Cortex (New York, N.Y. : 1991). PMID 27226444 DOI: 10.1093/Cercor/Bhw140 |
0.739 |
|
| 2016 |
España RA, Schmeichel BE, Berridge CW. Norepinephrine at the Nexus of Arousal, Motivation and Relapse. Brain Research. PMID 26773688 DOI: 10.1016/J.Brainres.2016.01.002 |
0.787 |
|
| 2015 |
Berridge CW, Spencer RC. Differential Cognitive Actions of Norepinephrine α2 and α1 Receptor Signaling in the Prefrontal Cortex. Brain Research. PMID 26592951 DOI: 10.1016/J.Brainres.2015.11.024 |
0.449 |
|
| 2015 |
Spencer RC, Devilbiss DM, Berridge CW. The cognition-enhancing effects of psychostimulants involve direct action in the prefrontal cortex. Biological Psychiatry. 77: 940-50. PMID 25499957 DOI: 10.1016/J.Biopsych.2014.09.013 |
0.763 |
|
| 2015 |
Berridge CW, Arnsten AFT. Catecholamine mechanisms in the prefrontal cortex: Proven strategies for enhancing higher cognitive function Current Opinion in Behavioral Sciences. 4: 33-40. DOI: 10.1016/J.Cobeha.2015.01.002 |
0.452 |
|
| 2014 |
Andrzejewski ME, Spencer RC, Harris RL, Feit EC, McKee BL, Berridge CW. The effects of clinically relevant doses of amphetamine and methylphenidate on signal detection and DRL in rats. Neuropharmacology. 79: 634-41. PMID 24467844 DOI: 10.1016/J.Neuropharm.2014.01.018 |
0.432 |
|
| 2014 |
Schmeichel BE, Berridge CW. Amphetamine acts within the lateral hypothalamic area to elicit affectively neutral arousal and reinstate drug-seeking. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 17: 63-75. PMID 23895988 DOI: 10.1017/S1461145713000734 |
0.775 |
|
| 2013 |
Schmeichel BE, Berridge CW. Neurocircuitry underlying the preferential sensitivity of prefrontal catecholamines to low-dose psychostimulants. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 1078-84. PMID 23303075 DOI: 10.1038/Npp.2013.6 |
0.788 |
|
| 2013 |
Schmeichel BE, Berridge CW. Wake-promoting actions of noradrenergic α1 - and β-receptors within the lateral hypothalamic area. The European Journal of Neuroscience. 37: 891-900. PMID 23252935 DOI: 10.1111/Ejn.12084 |
0.767 |
|
| 2013 |
Berridge CW, Arnsten AF. Psychostimulants and motivated behavior: arousal and cognition. Neuroscience and Biobehavioral Reviews. 37: 1976-84. PMID 23164814 DOI: 10.1016/J.Neubiorev.2012.11.005 |
0.47 |
|
| 2013 |
Schmeichel BE, Zemlan FP, Berridge CW. A selective dopamine reuptake inhibitor improves prefrontal cortex-dependent cognitive function: potential relevance to attention deficit hyperactivity disorder. Neuropharmacology. 64: 321-8. PMID 22796428 DOI: 10.1016/J.Neuropharm.2012.07.005 |
0.798 |
|
| 2013 |
Berridge CW, Devilbiss DM, Spencer RC, Schmeichel BE. Neural Mechanisms Underlying the Cognition-Enhancing Actions of Pyschostimulants: Relevance to ADHD Catecholamine Research in the 21st Century: Abstracts and Graphical Abstracts, 10th International Catecholamine Symposium, 2012. 168-169. DOI: 10.1016/B978-0-12-800044-1.00148-3 |
0.779 |
|
| 2012 |
Devilbiss DM, Jenison RL, Berridge CW. Stress-induced impairment of a working memory task: role of spiking rate and spiking history predicted discharge. Plos Computational Biology. 8: e1002681. PMID 23028279 DOI: 10.1371/Journal.Pcbi.1002681 |
0.739 |
|
| 2012 |
Devilbiss DM, Waterhouse BD, Berridge CW, Valentino R. Corticotropin-releasing factor acting at the locus coeruleus disrupts thalamic and cortical sensory-evoked responses. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 2020-30. PMID 22510725 DOI: 10.1038/Npp.2012.50 |
0.786 |
|
| 2012 |
Berridge CW, Schmeichel BE, España RA. Noradrenergic modulation of wakefulness/arousal. Sleep Medicine Reviews. 16: 187-97. PMID 22296742 DOI: 10.1016/J.Smrv.2011.12.003 |
0.787 |
|
| 2012 |
Spencer RC, Klein RM, Berridge CW. Psychostimulants act within the prefrontal cortex to improve cognitive function. Biological Psychiatry. 72: 221-7. PMID 22209638 DOI: 10.1016/J.Biopsych.2011.12.002 |
0.481 |
|
| 2012 |
Berridge CW, Shumsky JS, Andrzejewski ME, McGaughy JA, Spencer RC, Devilbiss DM, Waterhouse BD. Differential sensitivity to psychostimulants across prefrontal cognitive tasks: differential involvement of noradrenergic α₁ - and α₂-receptors. Biological Psychiatry. 71: 467-73. PMID 21890109 DOI: 10.1016/J.Biopsych.2011.07.022 |
0.789 |
|
| 2012 |
Berridge CW, Devilbiss DM, Spencer RC, Schmeichel BE, Arnsten AFT. Attention deficit hyperactivity disorder Translational Neuroscience: Applications in Psychiatry, Neurology, and Neurodevelopmental Disorders. 303-320. DOI: 10.1017/CBO9780511980053.018 |
0.761 |
|
| 2012 |
Berridge CW, Devilbiss DM. Psychostimulants as cognitive enhancers: The prefrontal cortex, catecholamines, and attention-deficit/hyperactivity disorder | Psicoestimulantes y potenciadores cognitivos: corteza prefrontal, catecolaminas y trastorno por déficit de atención/hiperactividad Psiquiatria Biologica. 19: 84-94. DOI: 10.1016/J.Psiq.2012.07.001 |
0.66 |
|
| 2011 |
Agster KL, Clark BD, Gao WJ, Shumsky JS, Wang HX, Berridge CW, Waterhouse BD. Experimental strategies for investigating psychostimulant drug actions and prefrontal cortical function in ADHD and related attention disorders. Anatomical Record (Hoboken, N.J. : 2007). 294: 1698-712. PMID 21901844 DOI: 10.1002/Ar.21403 |
0.671 |
|
| 2011 |
Berridge CW, Devilbiss DM. Psychostimulants as cognitive enhancers: the prefrontal cortex, catecholamines, and attention-deficit/hyperactivity disorder. Biological Psychiatry. 69: e101-11. PMID 20875636 DOI: 10.1016/J.Biopsych.2010.06.023 |
0.769 |
|
| 2011 |
Jenison RL, Berridge CW, Devilbiss DM. Decoding choice and mutual information on a moment-by-moment basis from single neurons in rat prefrontal cortex Bmc Neuroscience. 12. DOI: 10.1186/1471-2202-12-S1-P54 |
0.694 |
|
| 2011 |
Devilbiss DM, Berridge CW, Jenison RL. Conditional intensity/point process model of task-related prefrontal spiking: effects of performance Bmc Neuroscience. 12. DOI: 10.1186/1471-2202-12-S1-P160 |
0.725 |
|
| 2010 |
Berridge CW, España RA, Vittoz NM. Hypocretin/orexin in arousal and stress. Brain Research. 1314: 91-102. PMID 19748490 DOI: 10.1016/J.Brainres.2009.09.019 |
0.784 |
|
| 2009 |
Stalnaker TA, España RA, Berridge CW. Coping behavior causes asymmetric changes in neuronal activation in the prefrontal cortex and amygdala. Synapse (New York, N.Y.). 63: 82-5. PMID 18932226 DOI: 10.1002/Syn.20583 |
0.746 |
|
| 2008 |
Vittoz NM, Schmeichel B, Berridge CW. Hypocretin /orexin preferentially activates caudomedial ventral tegmental area dopamine neurons. The European Journal of Neuroscience. 28: 1629-40. PMID 18973582 DOI: 10.1111/J.1460-9568.2008.06453.X |
0.773 |
|
| 2008 |
Devilbiss DM, Berridge CW. Cognition-enhancing doses of methylphenidate preferentially increase prefrontal cortex neuronal responsiveness. Biological Psychiatry. 64: 626-35. PMID 18585681 DOI: 10.1016/J.Biopsych.2008.04.037 |
0.757 |
|
| 2008 |
Berridge CW. Noradrenergic modulation of arousal. Brain Research Reviews. 58: 1-17. PMID 18199483 DOI: 10.1016/J.Brainresrev.2007.10.013 |
0.473 |
|
| 2006 |
Conti LH, Berridge CW, Tayler JE. Both corticotropin-releasing factor and apomorphine reduce prepulse inhibition following repeated central infusion of corticotropin-releasing factor. Pharmacology, Biochemistry, and Behavior. 85: 261-72. PMID 16996121 DOI: 10.1016/J.Pbb.2006.08.009 |
0.335 |
|
| 2006 |
Devilbiss DM, Berridge CW. Low-dose methylphenidate actions on tonic and phasic locus coeruleus discharge. The Journal of Pharmacology and Experimental Therapeutics. 319: 1327-35. PMID 16980569 DOI: 10.1124/Jpet.106.110015 |
0.751 |
|
| 2006 |
Berridge CW. Neural substrates of psychostimulant-induced arousal. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 2332-40. PMID 16855535 DOI: 10.1038/Sj.Npp.1301159 |
0.442 |
|
| 2006 |
Berridge CW, Devilbiss DM, Andrzejewski ME, Arnsten AF, Kelley AE, Schmeichel B, Hamilton C, Spencer RC. Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function. Biological Psychiatry. 60: 1111-20. PMID 16806100 DOI: 10.1016/J.Biopsych.2006.04.022 |
0.809 |
|
| 2006 |
España RA, Berridge CW. Organization of noradrenergic efferents to arousal-related basal forebrain structures. The Journal of Comparative Neurology. 496: 668-83. PMID 16615125 DOI: 10.1002/Cne.20946 |
0.394 |
|
| 2006 |
Vittoz NM, Berridge CW. Hypocretin/orexin selectively increases dopamine efflux within the prefrontal cortex: involvement of the ventral tegmental area. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 384-95. PMID 15988471 DOI: 10.1038/Sj.Npp.1300807 |
0.807 |
|
| 2005 |
Berridge CW, Stellick RL, Schmeichel BE. Wake-promoting actions of medial basal forebrain beta2 receptor stimulation. Behavioral Neuroscience. 119: 743-51. PMID 15998195 DOI: 10.1037/0735-7044.119.3.743 |
0.745 |
|
| 2005 |
Berridge CW, España RA. Hypocretins: waking, arousal, or action? Neuron. 46: 696-8. PMID 15924855 DOI: 10.1016/J.Neuron.2005.05.016 |
0.366 |
|
| 2005 |
España RA, Reis KM, Valentino RJ, Berridge CW. Organization of hypocretin/orexin efferents to locus coeruleus and basal forebrain arousal-related structures. The Journal of Comparative Neurology. 481: 160-78. PMID 15562511 DOI: 10.1002/Cne.20369 |
0.395 |
|
| 2005 |
Berridge CW. Chapter 4.3 The locus coeruleus-noradrenergic system and stress: modulation of arousal state and state-dependent behavioral processes Techniques in the Behavioral and Neural Sciences. 15: 437-464. DOI: 10.1016/S0921-0709(05)80025-2 |
0.335 |
|
| 2005 |
Berridge CW, España RA. Hypocretin/orexin in stress and arousal Hypocretins: Integrators of Physiological Functions. 353-367. DOI: 10.1007/0-387-25446-3_24 |
0.601 |
|
| 2004 |
España RA, Berridge CW, Gammie SC. Diurnal levels of Fos immunoreactivity are elevated within hypocretin neurons in lactating mice. Peptides. 25: 1927-34. PMID 15501524 DOI: 10.1016/J.Peptides.2004.06.006 |
0.366 |
|
| 2003 |
España RA, Valentino RJ, Berridge CW. Fos immunoreactivity in hypocretin-synthesizing and hypocretin-1 receptor-expressing neurons: effects of diurnal and nocturnal spontaneous waking, stress and hypocretin-1 administration. Neuroscience. 121: 201-17. PMID 12946712 DOI: 10.1016/S0306-4522(03)00334-8 |
0.446 |
|
| 2003 |
Isaac SO, Berridge CW. Wake-promoting actions of dopamine D1 and D2 receptor stimulation. The Journal of Pharmacology and Experimental Therapeutics. 307: 386-94. PMID 12944496 DOI: 10.1124/Jpet.103.053918 |
0.384 |
|
| 2003 |
Stalnaker TA, Berridge CW. AMPA receptor stimulation within the central nucleus of the amygdala elicits a differential activation of central dopaminergic systems. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 28: 1923-34. PMID 12915861 DOI: 10.1038/Sj.Npp.1300268 |
0.731 |
|
| 2003 |
Baldo BA, Daniel RA, Berridge CW, Kelley AE. Overlapping distributions of orexin/hypocretin- and dopamine-beta-hydroxylase immunoreactive fibers in rat brain regions mediating arousal, motivation, and stress. The Journal of Comparative Neurology. 464: 220-37. PMID 12898614 DOI: 10.1002/Cne.10783 |
0.327 |
|
| 2003 |
Berridge CW, Waterhouse BD. The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes. Brain Research. Brain Research Reviews. 42: 33-84. PMID 12668290 DOI: 10.1016/S0165-0173(03)00143-7 |
0.678 |
|
| 2002 |
Berridge CW, Stalnaker TA. Relationship between low-dose amphetamine-induced arousal and extracellular norepinephrine and dopamine levels within prefrontal cortex. Synapse (New York, N.Y.). 46: 140-9. PMID 12325041 DOI: 10.1002/Syn.10131 |
0.739 |
|
| 2002 |
Lin SH, Arai AC, España RA, Berridge CW, Leslie FM, Huguenard JR, Vergnes M, Civelli O. Prolactin-releasing peptide (PrRP) promotes awakening and suppresses absence seizures. Neuroscience. 114: 229-38. PMID 12207968 DOI: 10.1016/S0306-4522(02)00248-8 |
0.659 |
|
| 2002 |
España RA, Plahn S, Berridge CW. Circadian-dependent and circadian-independent behavioral actions of hypocretin/orexin. Brain Research. 943: 224-36. PMID 12101045 DOI: 10.1016/S0006-8993(02)02653-7 |
0.365 |
|
| 2001 |
España RA, Baldo BA, Kelley AE, Berridge CW. Wake-promoting and sleep-suppressing actions of hypocretin (orexin): basal forebrain sites of action. Neuroscience. 106: 699-715. PMID 11682157 DOI: 10.1016/S0306-4522(01)00319-0 |
0.663 |
|
| 2001 |
Berridge CW, O'Neill J. Differential sensitivity to the wake-promoting actions of norepinephrine within the medial preoptic area and the substantia innominata. Behavioral Neuroscience. 115: 165-74. PMID 11256440 DOI: 10.1037/0735-7044.115.1.165 |
0.364 |
|
| 2000 |
Berridge CW, España RA. Synergistic sedative effects of noradrenergic alpha(1)- and beta-receptor blockade on forebrain electroencephalographic and behavioral indices. Neuroscience. 99: 495-505. PMID 11029541 DOI: 10.1016/S0306-4522(00)00215-3 |
0.357 |
|
| 2000 |
Berridge CW, Wifler K. Contrasting effects of noradrenergic beta-receptor blockade within the medial septal area on forebrain electroencephalographic and behavioral activity state in anesthetized and unanesthetized rat. Neuroscience. 97: 543-52. PMID 10828536 DOI: 10.1016/S0306-4522(00)00047-6 |
0.381 |
|
| 2000 |
Berridge CW, Morris MF. Amphetamine-induced activation of forebrain EEG is prevented by noradrenergic beta-receptor blockade in the halothane-anesthetized rat. Psychopharmacology. 148: 307-13. PMID 10755744 DOI: 10.1007/S002130050055 |
0.39 |
|
| 1999 |
Berridge CW, Abercrombie ED. Relationship between locus coeruleus discharge rates and rates of norepinephrine release within neocortex as assessed by in vivo microdialysis. Neuroscience. 93: 1263-70. PMID 10501450 DOI: 10.1016/S0306-4522(99)00276-6 |
0.381 |
|
| 1999 |
Berridge CW, O'Neil J, Wifler K. Amphetamine acts within the medial basal forebrain to initiate and maintain alert waking. Neuroscience. 93: 885-96. PMID 10473254 DOI: 10.1016/S0306-4522(99)00271-7 |
0.435 |
|
| 1999 |
Weninger SC, Dunn AJ, Muglia LJ, Dikkes P, Miczek KA, Swiergiel AH, Berridge CW, Majzoub JA. Stress-induced behaviors require the corticotropin-releasing hormone (CRH) receptor, but not CRH. Proceedings of the National Academy of Sciences of the United States of America. 96: 8283-8. PMID 10393986 DOI: 10.1073/Pnas.96.14.8283 |
0.376 |
|
| 1999 |
Berridge CW, Mitton E, Clark W, Roth RH. Engagement in a non-escape (displacement) behavior elicits a selective and lateralized suppression of frontal cortical dopaminergic utilization in stress. Synapse (New York, N.Y.). 32: 187-97. PMID 10340629 DOI: 10.1002/(Sici)1098-2396(19990601)32:3<187::Aid-Syn5>3.0.Co;2-9 |
0.454 |
|
| 1998 |
Berridge CW. Modulation of forebrain electroencephalographic activity and behavioral state by the locus ceruleus-noradrenergic system: involvement of the medial septal area. Advances in Pharmacology (San Diego, Calif.). 42: 744-8. PMID 9328006 DOI: 10.1016/S1054-3589(08)60855-8 |
0.438 |
|
| 1997 |
Berridge CW, Stratford TL, Foote SL, Kelley AE. Distribution of dopamine beta-hydroxylase-like immunoreactive fibers within the shell subregion of the nucleus accumbens. Synapse (New York, N.Y.). 27: 230-41. PMID 9329158 DOI: 10.1002/(Sici)1098-2396(199711)27:3<230::Aid-Syn8>3.0.Co;2-E |
0.378 |
|
| 1996 |
Berridge CW, Bolen SJ, Manley MS, Foote SL. Modulation of forebrain electroencephalographic activity in halothane-anesthetized rat via actions of noradrenergic beta-receptors within the medial septal region. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 16: 7010-20. PMID 8824337 DOI: 10.1523/Jneurosci.16-21-07010.1996 |
0.343 |
|
| 1996 |
Berridge CW, Foote SL. Enhancement of behavioral and electroencephalographic indices of waking following stimulation of noradrenergic beta-receptors within the medial septal region of the basal forebrain. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 16: 6999-7009. PMID 8824336 DOI: 10.1523/Jneurosci.16-21-06999.1996 |
0.386 |
|
| 1994 |
Davis M, Hitchcock JM, Bowers MB, Berridge CW, Melia KR, Roth RH. Stress-induced activation of prefrontal cortex dopamine turnover: blockade by lesions of the amygdala. Brain Research. 664: 207-10. PMID 7895029 DOI: 10.1016/0006-8993(94)91972-0 |
0.392 |
|
| 1994 |
Berridge CW, Foote SL. Locus coeruleus-induced modulation of forebrain electroencephalographic (EEG) state in halothane-anesthetized rat. Brain Research Bulletin. 35: 597-605. PMID 7859117 DOI: 10.1016/0361-9230(94)90174-0 |
0.405 |
|
| 1993 |
Moghaddam B, Berridge CW, Goldman-Rakic PS, Bunney BS, Roth RH. In vivo assessment of basal and drug-induced dopamine release in cortical and subcortical regions of the anesthetized primate. Synapse (New York, N.Y.). 13: 215-22. PMID 8497807 DOI: 10.1002/Syn.890130304 |
0.386 |
|
| 1993 |
Berridge CW, Arnsten AF, Foote SL. Noradrenergic modulation of cognitive function: clinical implications of anatomical, electrophysiological and behavioural studies in animal models. Psychological Medicine. 23: 557-64. PMID 8234565 DOI: 10.1017/S0033291700025332 |
0.335 |
|
| 1993 |
Page ME, Berridge CW, Foote SL, Valentino RJ. Corticotropin-releasing factor in the locus coeruleus mediates EEG activation associated with hypotensive stress. Neuroscience Letters. 164: 81-4. PMID 8152620 DOI: 10.1016/0304-3940(93)90862-F |
0.385 |
|
| 1993 |
Berridge CW, Page ME, Valentino RJ, Foote SL. Effects of locus coeruleus inactivation on electroencephalographic activity in neocortex and hippocampus. Neuroscience. 55: 381-93. PMID 8104319 DOI: 10.1016/0306-4522(93)90507-C |
0.39 |
|
| 1991 |
Foote SL, Berridge CW, Adams LM, Pineda JA. Electrophysiological evidence for the involvement of the locus coeruleus in alerting, orienting, and attending. Progress in Brain Research. 88: 521-32. PMID 1813932 DOI: 10.1016/S0079-6123(08)63831-5 |
0.419 |
|
| 1991 |
Bradberry CW, Gruen RJ, Berridge CW, Roth RH. Individual differences in behavioral measures: correlations with nucleus accumbens dopamine measured by microdialysis. Pharmacology, Biochemistry, and Behavior. 39: 877-82. PMID 1763106 DOI: 10.1016/0091-3057(91)90047-6 |
0.39 |
|
| 1990 |
Spadaro F, Berridge CW, Baldwin HA, Dunn AJ. Corticotropin-releasing factor acts via a third ventricle site to reduce exploratory behavior in rats. Pharmacology, Biochemistry, and Behavior. 36: 305-9. PMID 2356205 DOI: 10.1016/0091-3057(90)90408-A |
0.35 |
|
| 1990 |
Berridge CW, Dunn AJ. DSP-4-induced depletion of brain norepinephrine produces opposite effects on exploratory behavior 3 and 14 days after treatment. Psychopharmacology. 100: 504-8. PMID 2320711 DOI: 10.1007/Bf02244003 |
0.306 |
|
| 1990 |
Dunn AJ, Berridge CW. Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses? Brain Research. Brain Research Reviews. 15: 71-100. PMID 1980834 DOI: 10.1016/0165-0173(90)90012-D |
0.329 |
|
| 1989 |
Berridge CW, Dunn AJ. Restraint-stress-induced changes in exploratory behavior appear to be mediated by norepinephrine-stimulated release of CRF. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 9: 3513-21. PMID 2795137 DOI: 10.1523/Jneurosci.09-10-03513.1989 |
0.376 |
|
| 1989 |
Berridge CW, Dunn AJ. CRF and restraint-stress decrease exploratory behavior in hypophysectomized mice. Pharmacology, Biochemistry, and Behavior. 34: 517-9. PMID 2623010 DOI: 10.1016/0091-3057(89)90551-0 |
0.336 |
|
| 1987 |
Dunn AJ, Berridge CW, Lai YI, Yachabach TL. CRF-induced excessive grooming behavior in rats and mice. Peptides. 8: 841-4. PMID 3501576 DOI: 10.1016/0196-9781(87)90069-6 |
0.321 |
|
| 1987 |
Berridge CW, Dunn AJ. A corticotropin-releasing factor antagonist reverses the stress-induced changes of exploratory behavior in mice. Hormones and Behavior. 21: 393-401. PMID 3499373 DOI: 10.1016/0018-506X(87)90023-7 |
0.369 |
|
| 1987 |
Dunn AJ, Berridge CW. Corticotropin-releasing factor administration elicits a stress-like activation of cerebral catecholaminergic systems. Pharmacology, Biochemistry, and Behavior. 27: 685-91. PMID 2443934 DOI: 10.1016/0091-3057(87)90195-X |
0.399 |
|
| 1986 |
Berridge CW, Dunn AJ. Corticotropin-releasing factor elicits naloxone sensitive stress-like alterations in exploratory behavior in mice. Regulatory Peptides. 16: 83-93. PMID 3492730 DOI: 10.1016/0167-0115(86)90196-5 |
0.379 |
|
| 1986 |
Dunn AJ, Elfvin KL, Berridge CW. Changes in plasma corticosterone and cerebral biogenic amines and their catabolites during training and testing of mice in passive avoidance behavior. Behavioral and Neural Biology. 46: 410-23. PMID 2434072 DOI: 10.1016/S0163-1047(86)90422-X |
0.305 |
|
| 1985 |
Arnsten AF, Berridge C, Segal DS. Stress produces opioid-like effects on investigatory behavior. Pharmacology, Biochemistry, and Behavior. 22: 803-9. PMID 4011639 DOI: 10.1016/0091-3057(85)90531-3 |
0.358 |
|
| Show low-probability matches. |